Equity [Abstract] Cash dividends declared per common share (in dollars per share) Common Stock, Dividends, Per Share, Declared Accounting Policies [Abstract] Schedule of inventories Schedule of Inventory, Current [Table Text Block] Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Supplemental Financial Information Interest Expense, Net Interest Revenue (Expense), Net [Abstract] Interest expense Interest Expense Interest income Investment Income, Interest and Dividend Interest expense, net Interest Income (Expense), Nonoperating, Net Accounts Payable and Accrued Liabilities Accounts Payable and Accrued Liabilities, Current [Abstract] Sales rebates Accrued Sales Rebates Carrying amount as of the balance sheet date of accrued sales rebates. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Dividends payable Dividends Payable, Current Accounts payable Accounts Payable, Current Salaries, wages and commissions Employee-related Liabilities, Current Royalty and license arrangements Accrued Royalties, Current Other Other Accrued Liabilities, Current Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Other Long-Term Liabilities Liabilities, Other than Long-term Debt, Noncurrent [Abstract] Contingent consideration liabilities Business Combination, Contingent Consideration, Liability, Noncurrent Income taxes payable Accrued Income Taxes, Noncurrent Pension and other post-employment benefits Liability, Defined Benefit Plan, Noncurrent Liabilities for unrecognized tax benefits Unrecognized Tax Benefits Liabilities Represents unrecognized tax benefits liabilities. Other Other Liabilities, Noncurrent Other long-term liabilities Liabilities, Other than Long-term Debt, Noncurrent Fair Value Disclosures [Abstract] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign currency forward exchange contracts Foreign Exchange Forward [Member] Interest rate swap contracts Interest Rate Swap [Member] Treasury rate lock agreements Treasury Lock [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as hedging instrument Designated as Hedging Instrument [Member] Not designated as hedges Not Designated as Hedging Instrument [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of products sold Cost of Sales [Member] Interest expense, net Interest Expense [Member] Net foreign exchange loss Foreign Currency Gain (Loss) [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior notes Senior Notes [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash flow hedges Cash Flow Hedging [Member] Net investment hedges Net Investment Hedging [Member] Fair value hedges Fair Value Hedging [Member] Gain (loss) on derivatives Derivative Instruments, Gain (Loss) [Line Items] Pre-tax gains (losses) from cash flow hedges recognized in other comprehensive income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Pre-tax gains (losses) from net investment hedges recognized in other comprehensive income Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Pre-tax losses to be transferred into cost of products sold for foreign currency cash flow hedges during the next 12 months Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Pre-tax gains to be transferred into interest expense, net for interest rate swap cash flow hedges during the next 12 months Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Pre-tax gains to be transferred into interest expense, net for treasury rate lock agreement cash flow hedges during the next 12 months Treasury Lock Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Treasury Rate Lock Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Derivative instrument net gains (losses) recognized in the consolidated statements of earnings Derivative, Gain (Loss) on Derivative, Net Debt designated as hedged item in fair value hedges gains (losses) recognized in the consolidated statements of earnings Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge Income Tax Disclosure [Abstract] Unrecognized Tax Benefits Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Beginning balance Unrecognized Tax Benefits Increase due to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Increase due to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Decrease due to prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Lapse of statutes of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Ending balance Net amount of potential tax benefits that would impact the entity's effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Reimbursement receivable for unrecognized tax benefits and related interest and penalties for periods after separation Reimbursement Receivable for Unrecognized Tax Benefit and Related Interest and Penalties Represents the amount of reimbursement receivable for unrecognized tax benefits and related interest and penalties. Interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Accrued interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Reasonably possible amount that gross unrecognized tax benefits may change within the next twelve months, high end of range Decrease in Unrecognized Tax Benefits is Reasonably Possible Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Schedule of earnings before income tax expense Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of income tax expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Summary of effective tax rate reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of deferred tax assets and liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of unrecognized tax benefits Summary of Income Tax Contingencies [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Basis of Consolidation Consolidation, Policy [Policy Text Block] Revenue Recognition Revenue [Policy Text Block] Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Collaborations and Other Arrangements Collaborative Arrangement, Accounting Policy [Policy Text Block] Advertising Advertising Cost [Policy Text Block] Pension and Other Post-Employment Benefits Pension and Other Postretirement Plans, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Cash and Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Investments Investment, Policy [Policy Text Block] Accounts Receivable Accounts Receivable [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Short-Term Leases Short-term Leases [Policy Text Block] Litigation and Contingencies Commitments and Contingencies, Policy [Policy Text Block] Business Combinations Business Combinations Policy [Policy Text Block] Goodwill and Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Acquired In-Process Research and Development In Process Research and Development, Policy [Policy Text Block] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Derivatives Derivatives, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Postemployment Benefits [Abstract] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Defined benefit plans Pension Plan [Member] Other post-employment plans Other Postretirement Benefits Plan [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Projected benefit obligations Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Beginning of period Defined Benefit Plan, Benefit Obligation Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Employee contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Actuarial (gain) loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Other, primarily foreign currency translation adjustments Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) End of period Fair value of plan assets Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Beginning of period Defined Benefit Plan, Plan Assets, Amount Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Company contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Employee contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Other, primarily foreign currency translation adjustments Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) End of period Funded status, end of period Defined Benefit Plan, Funded (Unfunded) Status of Plan Amounts recognized on the consolidated balance sheets Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract] Other assets Assets for Plan Benefits, Defined Benefit Plan Accounts payable and accrued liabilities Liability, Defined Benefit Plan, Current Other long-term liabilities Net obligation Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Actuarial loss, net Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax Prior service cost (credit) Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax Accumulated other comprehensive loss Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common stock Common Stock [Member] Treasury stock Treasury Stock [Member] Additional paid-in capital Additional Paid-in Capital [Member] Retained earnings Retained Earnings [Member] Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance Stockholders' Equity Attributable to Parent Beginning balance (in shares) Shares, Outstanding Net earnings Net Income (Loss) Attributable to Parent Other comprehensive income, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Dividends declared Dividends, Common Stock, Cash Purchases of treasury stock Treasury Stock, Value, Acquired, Cost Method Purchases of treasury stock (in shares) Treasury Stock, Shares, Acquired Stock-based compensation plans and other Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Stock-based compensation plans and other (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Adoption of new accounting standards Cumulative Effect of New Accounting Principle in Period of Adoption Ending balance Ending balance (in shares) Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Quoted prices in active markets for identical assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant other observable inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] U.S. Large Cap U S Large Capital Equity Securities [Member] Represents information pertaining to equity securities which have a large size capitalization, generally 5 billion dollars or more. U.S. mid cap U S Mid Capital Equity Securities [Member] Represents information pertaining to equity securities which have a medium size capitalization, generally 1 billion to 5 billion dollars. International Foreign Equity Securities [Member] Represents information pertaining to equity securities invested in a foreign publicly-traded company. U.S. government securities US Treasury and Government [Member] Corporate debt instruments Corporate Debt Securities [Member] Non-U.S. government securities Debt Security, Government, Non-US [Member] Other fixed income securities Other Debt Obligations [Member] Absolute return funds Fixed Income Funds [Member] Real assets Real Estate [Member] Other real assets Defined Benefit Plan Other Assets [Member] Represents information relating to Defined Benefit Plan for other Assets. Total Total Plan Assets [Member] Total Plan Assets [Member] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Total assets measured at NAV Defined Benefit Plan, Fair Value of Plan Assets, Net Asset Value Defined Benefit Plan, Fair Value of Plan Assets, Net Asset Value Fair value of plan assets Segment Reporting [Abstract] Number of Operating Segments Number of Operating Segments Number of Principal US Customers Number of Principal US Customers Represents the number of principal U.S. customers of the entity. Post-Employment Benefits Postemployment Benefits Disclosure [Text Block] Leases [Abstract] Summary of amounts and location of operating and finance leases on the consolidated balance sheet Operating and Finance Lease Balance Sheet Disclosure [Table Text Block] Operating and Finance Lease Balance Sheet Disclosure [Table Text Block] Summary of lease costs recognized in the condensed consolidated statement of earnings Lease, Cost [Table Text Block] Schedule of weighted-average remaining lease term and weighted-average discount rate for operating and finance leases Operating and Finance Lease Weighted-Average Remaining Lease Term and Discount Rate [Table Text Block] Operating and Finance Lease Weighted-Average Remaining Lease Term and Discount Rate [Table Text Block] Schedule of supplementary cash flow information regarding the company's leases Operating Lease Cash Flow Disclosure [Table Text Block] Operating Lease Cash Flow Disclosure [Table Text Block] Summary of future maturities of AbbVie's finance lease liabilities Finance Lease, Liability, Maturity [Table Text Block] Summary of future maturities of AbbVie's operating lease liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Actuarial loss Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Amortization of actuarial loss and prior service credit Defined Benefit Plan, Amounts Recognized In Other Comprehensive Income (Loss), Amortization Of Actuarial (Gain) Loss And Prior Service Cost (Credit), before Tax Represents the adjustment out of other comprehensive income for amortization of prior service cost and actuarial gains losses recognized during the period, before tax. Foreign exchange loss (gain) and other Defined Benefit Plan Amounts Recognized in Other Comprehensive Income Foreign Exchange Gain (Loss) before Tax Represents the adjustment out of other comprehensive income for foreign exchange gains (losses) recognized during the period, before tax. Total loss (gain) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Statement of Comprehensive Income [Abstract] Foreign currency translation adjustments, tax expense (benefit) Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent Hedging activities, tax expense (benefit) Other Comprehensive Income (Loss), Net Investment Hedge, Tax, Portion Attributable to Parent Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on derivative instruments and nonderivative instruments designated and qualifying as net investment hedge, attributable to parent entity. Pension and post-employment benefits, tax expense (benefit) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent Marketable security activities, tax expense (benefit) Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent Hedging activities, tax expense (benefit) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent Schedule of net revenues by product Disaggregation of Revenue [Table Text Block] Schedule of net revenues to external customers by geographic area Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Schedule of long-lived assets by geographic area Long-lived Assets by Geographic Areas [Table Text Block] Restructuring and Related Activities [Abstract] Summary of the cash activity in the restructuring reserve Restructuring and Related Costs [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Other operating income Other Operating Income (Expense) [Member] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency Nature [Domain] Loss Contingency, Nature [Domain] Patent Litigation Patent Litigation [Member] Represents information pertaining to litigation related to patent disputes. Disgorgement Remedy DisgorgementRemedy [Member] Disgorgement remedy Litigation Case [Axis] Litigation Case [Axis] Litigation Case Type [Domain] Litigation Case [Domain] AndroGel Antitrust Litigation Andro Gel Antitrust Litigation [Member] Represents information pertaining to AndroGel Antitrust Litigation. Niaspan Niaspan [Member] Represents information pertaining to Niaspan, a product of the entity. Elliott Associates, L.P. Elliott Associates, L.P. [Member] Represents information pertaining to Elliot Associates, LP. Testosterone Replacement Therapy Products Liability Litigation Testosterone Replacement Therapy Products Liability Litigation [Member] Information relating to Testosterone Replacement Therapy Products Liability Litigation. Depakote Depakote [Member] Represents information concerning Depakote-related claims. Novartis Vaccines and Diagnostics Inc and Grifols Worldwide Operations Ltd Novartis Vaccines and Diagnostics Inc and Grifols Worldwide Operations Ltd [Member] Novartis Vaccines and Diagnostics, Inc. and Grifols Worldwide Operations Ltd. Legal Proceedings and Contingencies Loss Contingencies [Line Items] Recorded accrual balance for litigation Loss Contingency Accrual Legal settlement income Legal Settlement Income Represents the amount received for legal settlement. Number of generic companies with whom certain litigation related agreements were entered into Loss Contingency Number of Generic Companies as Counterparty of Litigation Related Agreements Violated Certain Laws Represents the number of generic companies with whom certain litigation related agreements are entered into that violated federal and state antitrust laws and state consumer protection and unjust enrichment laws. Damages awarded against company Loss Contingency, Damages Awarded, Value Number of healthcare benefit providers who filed lawsuits Loss Contingency, Number of Plaintiffs Number of individual plaintiff lawsuits Loss Contingency Individual Plaintiff Lawsuits Number Represents the number of individual plaintiff lawsuits filed, pertaining to a loss contingency during the period. Number of purported class actions Loss Contingency Purported Class Actions Number Represents the number of purported class actions filed, pertaining to a loss contingency during the period. Number of individual putative class action lawsuit Putative Class Action Lawsuit Individual Number Represents number of the number of individual putative class action lawsuit. Number of parties to lawsuit (in investment funds) Loss Contingency, New Claims Filed, Number Numbers of cases are consolidated for pre-trial purposes Number Of Cases Consolidated For Pre-trial Purposes Numbers of cases are consolidated for pre-trial purposes. Number of cases pending Loss Contingency, Pending Claims, Number Percentage of claims subject to settlement agreements Percentage of Claims Subject to Settlement Agreements Percentage of claims subject to settlement agreements HCV-related patents Gain Contingency, Patents Allegedly Infringed upon, Number Supplemental Financial Information Additional Financial Information Disclosure [Text Block] Debt, Credit Facilities, and Commitments and Contingencies Long-term Debt, Fiscal Year Maturity [Abstract] 2020 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2021 Long-term Debt, Maturities, Repayments of Principal in Year Two 2022 Long-term Debt, Maturities, Repayments of Principal in Year Three 2023 Long-term Debt, Maturities, Repayments of Principal in Year Four 2024 Long-term Debt, Maturities, Repayments of Principal in Year Five Thereafter Long-term Debt, Maturities, Repayments of Principal after Year Five Total obligations and commitments Long-term Debt Fair value hedges, unamortized bond discounts, deferred financing costs and finance lease obligations Long Term Debt And Capital Lease Obligations Fair Value Hedges Unamortized Bond Discounts Deferred Financing Costs And Finance Lease Obligations Represents the total amount of fair value hedges, unamortized bond discounts, deferred financing costs and finance lease obligations related to long term debt and capital lease obligations. Total long-term debt and finance lease obligations Debt and Lease Obligation Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States and Puerto Rico United States And Puerto Rico [Member] Represents information pertaining to United States and Puerto Rico. Europe Europe [Member] All other All Other Countries [Member] All Other Countries [Member] Revenues from External Customers and Long-Lived Assets Revenues from External Customers and Long-Lived Assets [Line Items] Total long-lived assets Long-Lived Assets Effect of one percentage point increase, Service cost and interest cost Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components Effect of one percentage point decrease, Service cost and interest cost Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components Effect of one percentage point increase, Projected benefit obligation Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation Effect of one percentage point decrease, Projected benefit obligation Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation Collaboration with Janssen Biotech, Inc. No definition available. Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Arrangements And Nonarrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative arrangement Collaborative Arrangement [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Janssen Biotech, Inc Janssen Biotech Inc [Member] Represents the information pertains to the entity Janssen Biotech Inc. United States UNITED STATES International Non-US [Member] Collaborative Arrangements and Non-collaborative Arrangement Transactions Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Milestone payments Collaborative Arrangement Milestone Method Payments Receivable The maximum milestone payments that may be received by the entity based on the achievement of specified events under a collaborative arrangement. Share of collaboration development costs responsible by Janssen Collaborative Arrangements Percentage Of Share Of Development Costs Responsible By Third Party Represents the percentage of share in collaboration development costs responsible by Janssen under cost sharing arrangement. Share of collaboration development costs responsible by the entity Collaborative Arrangements Percentage Of Share Of Development Costs Represents the percentage of share in collaboration development costs responsible by the entity under cost sharing arrangement. United States - Janssen's share of profits (included in cost of products sold) Collaborative Arrangements Payment To Other Party As Share Of Profits Before Income Taxes Represents the amount paid or to be paid to other party as profit sharing in the contract which is recorded as expense for the company. International - AbbVie's share of profits (included in net revenues) Collaborative Arrangements Share Of Profits Before Income Taxes Represents the amount of share of profits before income taxes under the collaborative arrangements. Global - AbbVie's share of other costs (included in respective line items) Cost Sharing Expenses Represents cost sharing expenses. Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Accounts payable and accrued liabilities Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property Plant And Equipment Type [Domain] Property, Plant and Equipment, Type [Domain] Land Land [Member] Equipment Building [Member] Equipment Equipment [Member] Construction in progress Construction in Progress [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Property and Equipment Property, Plant and Equipment [Line Items] Property and equipment, gross Property, Plant and Equipment, Gross Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, net Property, Plant and Equipment, Net Estimated useful lives Property, Plant and Equipment, Useful Life Amortization period of software costs included in equipment Finite-Lived Intangible Assets, Remaining Amortization Period Depreciation expense Depreciation Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other assets Other Noncurrent Assets [Member] Property and equipment, net Property, Plant and Equipment [Member] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities [Member] Other long-term liabilities Other Noncurrent Liabilities [Member] Current portion of long-term debt and finance lease obligations LongTermDebtandFinanceLeaseObligationsCurrent [Member] Refers to long-term debt and finance lease obligations due within one year or the normal operating cycle, if longer. Long-term debt and finance lease obligations LongTermDebtandFinanceLeaseObligations [Member] Refers to long-term debt and finance lease obligations due after one year or beyond the normal operating cycle, if longer. Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Assets Assets [Abstract] Operating lease assets Operating Lease, Right-of-Use Asset Finance lease assets Finance Lease, Right-of-Use Asset Total lease assets Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating and finance leases. Liabilities Liabilities [Abstract] Current operating lease liabilities Operating Lease, Liability, Current Noncurrent operating lease liabilities Operating Lease, Liability, Noncurrent Current finance lease liabilities Finance Lease, Liability, Current Noncurrent finance lease liabilities Finance Lease, Liability, Noncurrent Total lease liabilities Lease, Liability Present value of lessee's discounted obligation for lease payments from operating and finance leases. Restructuring Plans Restructuring and Related Activities Disclosure [Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Employee Severance Employee Severance [Member] Restructuring charges Restructuring Cost and Reserve [Line Items] Restructuring charges Restructuring Charges Restructuring reserve Restructuring Reserve [Roll Forward] Accrued balance beginning of the period Restructuring Reserve Restructuring charges Payments and other adjustments Restructuring Reserve Period Cash Settled and Other Adjustments The change in the restructuring reserve related to the amount of cash paid and other adjustments during the period. Accrued balance end of the period Advertising expenses Advertising Expense Amortization period of differences between the expected and actual return on plan assets Amortization Period of Differences between the Expected Long Term Return on Plan Assets and the Actual Return Represents the period over which differences between the expected long-term return on plan assets and the actual return will be amortized. Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2016-02 Accounting Standards Update 2016-02 [Member] New Accounting Pronouncements or Change in Accounting Principle New Accounting Pronouncements or Change in Accounting Principle [Line Items] Other assets Other Assets, Noncurrent Other long-term liabilities Discount rate for determining service cost Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Service Cost, Discount Rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Service Cost, Discount Rate Discount rate for determining interest cost Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Interest Cost, Discount Rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Interest Cost, Discount Rate Expected long-term rate of return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Expected rate of change in compensation Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Weighted-average remaining lease term for operating leases Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term for finance leases Finance Lease, Weighted Average Remaining Lease Term Weighted-average discount rate for operating leases Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate for finance leases Finance Lease, Weighted Average Discount Rate, Percent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] RSUs Restricted Stock Units (RSUs) [Member] Performance-vested RSUs Performance-based Restricted Stock Units [Member] Performance-based Restricted Stock Units [Member] Performance shares Performance Shares [Member] RSUs and performance shares Restricted Stock Units And Performance Shares [Member] Restricted Stock Units And Performance Shares [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Incremental vesting Share Based Compensation Arrangement by Share Based Payment Award Options Portion of Awards Vesting in Annual Increments Represents the portion of share options (or share units) granted during the period under equity-based awards, which will vest in annual increments. Performance period Share-based Compensation Arrangement by Share-based Payment Award, Performance Period Share-based Compensation Arrangement by Share-based Payment Award, Performance Period Common stock received for each vested award (in shares) Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Number of Shares to be Issued upon Vesting for Each Award Vested Represents the number of shares of common stock to be received by recipient upon vesting for each equity-based awards, excluding options, vested. Share units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Shares units outstanding at the beginning of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Shares units outstanding at the end of the period (in shares) Weighted-average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted average fair value outstanding at the beginning of the period (in dollars per share) Share Based Compensation Arrangement by Share Based Payment Award, Non Option Equity Instruments Outstanding Weighted Average Grant Date Fair Value Represents the weighted average fair value of non-option equity instrument agreements awarded that validly exist and are outstanding, including vested instruments. Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited (in dollars per share) Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Expired Weighted Average Grant Date Fair Value Represents the weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that expired during the period. Weighted average fair value outstanding at the end of the period (in dollars per share) Fair market value of awards vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Period for recognition of unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of accumulated other comprehensive income Reclassification out of Accumulated Other Comprehensive Income [Member] Net investment hedging activities Net investment hedging activities AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member] Pension and post-employment benefits Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Cash flow hedging activities Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Significant amounts reclassified out of each component of AOCI Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Gains on derivatives recognized in interest expense, net reclassified out of other comprehensive income Tax expense (benefit) Income Tax Expense (Benefit) Total reclassifications, net of tax Amortization of actuarial losses and other Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Tax benefit Reclassification from AOCI, Current Period, Tax Total reclassifications, net of tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Losses (gains) on foreign currency exchange contracts Cost of Goods and Services Sold Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Financial Instrument [Axis] Financial Instrument [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Short-term Investments Short-term Investments [Member] Asset backed securities Asset-backed Securities [Member] Corporate debt securities Other debt securities Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Debt securities classified as short-term Debt Securities, Available-for-sale Debt security maturity period Available-for-sale Securities, Maturity Period of Securities, Maximum Maximum period of maturity for available-for-sale securities, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Amortized cost Available-for-sale Securities, Amortized Cost Basis Gross unrealized gains Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Gross unrealized losses Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Fair value Available-for-sale Securities Other than temporary impairments Accumulated Other Comprehensive Income (Loss), Other than Temporary Impairment, Not Credit Loss, Net of Tax, Available-for-sale, Debt Securities Net realized gains on available-for-sale securities Available-for-sale Securities, Gross Realized Gain (Loss) Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Rate of compensation increases Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Statement of Financial Position [Abstract] Current assets Assets, Current [Abstract] Cash and equivalents Cash and Cash Equivalents, at Carrying Value Short-term investments Short-term Investments Inventories Inventory, Net Prepaid expenses and other Prepaid Expense and Other Assets Total current assets Assets, Current Investments Long-term Investments Property and equipment, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Total assets Assets Liabilities and Equity Liabilities and Equity [Abstract] Current liabilities Liabilities, Current [Abstract] Short-term borrowings Short-term Debt Current portion of long-term debt and finance lease obligations Long-term Debt and Lease Obligation, Current Total current liabilities Liabilities, Current Long-term debt and finance lease obligations Long-term Debt and Lease Obligation Deferred income taxes Deferred Tax Liabilities, Net, Noncurrent Commitments and contingencies Commitments and Contingencies Stockholders’ equity (deficit) Stockholders' Equity Attributable to Parent [Abstract] Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,781,582,608 shares issued as of December 31, 2019 and 1,776,510,871 as of December 31, 2018 Common Stock, Value, Outstanding Common stock held in treasury, at cost, 302,671,146 shares as of December 31, 2019 and 297,686,473 as of December 31, 2018 Treasury Stock, Value Additional paid-in capital Additional Paid in Capital, Common Stock Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total stockholders’ equity (deficit) Total liabilities and equity Liabilities and Equity Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value Measurement Frequency [Domain] Measurement Frequency [Domain] Recurring Fair Value, Recurring [Member] Foreign currency contracts Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Time deposits Bank Time Deposits [Member] Contingent Consideration Change, By Type [Axis] Contingent Consideration Change, By Type [Axis] Contingent Consideration Change, By Type [Axis] Contingent Consideration Change, By Type [Domain] Contingent Consideration Change, By Type [Domain] [Domain] for Contingent Consideration Change, By Type [Axis] Change in assumed discount rate Change In Assumed Discount Rate [Member] Change In Assumed Discount Rate [Member] Change in assumed probability rate Change In Assumed Probability Rate [Member] Change In Assumed Probability Rate [Member] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Changes Measurement Changes Measurement [Member] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] SKYRIZI SKYRIZI [Member] Represents information pertaining to SKYRIZI, a product of the entity. Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Stemcentrx Inc. Stemcentrx Inc. [Member] Represents the information pertaining to acquisition of Stemcentrx, Inc. Fair value, asset and liability measures Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets Assets, Fair Value Disclosure [Abstract] Cash and equivalents Cash and Cash Equivalents, Fair Value Disclosure Time deposits Investments, Fair Value Disclosure Debt securities Equity securities Equity Securities, FV-NI Interest rate swap contracts Interest Rate Derivative Assets, at Fair Value Equity securities Available-for-sale Securities, Equity Securities Foreign currency contracts Derivative Asset, Fair Value, Gross Asset Total assets Assets, Fair Value Disclosure Liabilities Liabilities, Fair Value Disclosure [Abstract] Interest rate swap contracts Interest Rate Derivative Liabilities, at Fair Value Foreign currency contracts Derivative Liability, Fair Value, Gross Liability Contingent consideration Business Combination, Contingent Consideration, Liability Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Discount rate change Fair Value Inputs, Discount Rate Change Fair Value Inputs, Assumed Discount Rate Change Contingent consideration liability change Business Combination, Contingent Consideration Arrangements, Potential Change in Amount of Contingent Consideration, Liability Business Combination, Contingent Consideration Arrangements, Potential Change in Amount of Contingent Consideration, Liability Assumed probability rate change Fair Value Inputs, Assumed Probability Rate Change Fair Value Inputs, Assumed Probability Rate Change Change in fair value recognized in net earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Financial Instruments and Fair Value Measures Derivatives and Fair Value [Text Block] Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Data (unaudited) Quarterly Financial Information [Text Block] Earnings Per Share [Abstract] Earnings Per Share Earnings Per Share [Text Block] Concentration Risk [Table] Concentration Risk [Table] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Net revenues Revenue Benchmark [Member] Accounts Receivable Accounts Receivable [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Geographic Risk Geographic Concentration Risk [Member] HUMIRA Product Concentration Risk [Member] Concentration of Risk Concentration Risk [Line Items] Number of principal customers Concentrations risk (as a percent) Concentration Risk, Percentage Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, authorized (in shares) Common Stock, Shares Authorized Common stock, issued (in shares) Common Stock, Shares, Issued Common stock held in treasury, at cost (in shares) Treasury Stock, Shares Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] May 2018 term loan credit agreement May 2018 Term Loan Credit Agreement [Member] May 2018 Term Loan Credit Agreement Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Commercial Paper Commercial Paper [Member] Term loan facilities Loans Payable [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving credit facility Revolving Credit Facility [Member] Short-term borrowings Short-term Debt [Line Items] Weighted-average interest rate on commercial paper (as a percent) Short-term Debt, Weighted Average Interest Rate, at Point in Time Revolving credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Revolving credit facility term Line of Credit Facility, Expiration Period Revolving credit facility outstanding Long-term Line of Credit Repayments of other short-term borrowings Repayments of Other Short-term Debt Term loan credit agreement term Debt Instrument, Term Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Cover page. Entities [Table] Entities [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Sec 1.375 Senior Notes Due 2024 [Member] Sec 1.375 Senior Notes Due 2024 [Member] Sec 1.375 Senior Notes Due 2024 [Member] Sec 0.750 Senior Notes Due 2027 [Member] Sec 0.750 Senior Notes Due 2027 [Member] Sec 0.750 Senior Notes Due 2027 [Member] Sec 2.125 Senior Notes due 2028 [Member] Sec 2.125 Senior Notes due 2028 [Member] Sec 2.125 Senior Notes due 2028 [Member] Sec 1.250 Senior Notes due 2031 [Member] Sec 1.250 Senior Notes due 2031 [Member] Sec 1.250 Senior Notes due 2031 [Member] Entity Listings, Exchange [Axis] Entity Listings, Exchange [Axis] Exchange [Domain] Exchange [Domain] NEW YORK STOCK EXCHANGE, INC. [Member] NEW YORK STOCK EXCHANGE, INC. [Member] CHICAGO STOCK EXCHANGE, INC [Member] CHICAGO STOCK EXCHANGE, INC [Member] Entity Information [Line Items] Entity Information [Line Items] Document Type Document Type Document Annual Report Document Annual Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entry Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Public Float Entity Public Float Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Current Fiscal Year End Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Organization, Consolidation and Presentation of Financial Statements [Abstract] Percentage of outstanding common stock distributed to Abbott shareholders Percentage of Outstanding Common Stock Distributed Represents the percentage of outstanding common stock distributed to shareholders. Basic EPS Earnings Per Share, Basic, Two Class Method [Abstract] Earnings allocated to participating securities Participating Securities, Distributed and Undistributed Earnings (Loss), Basic Earnings available to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Weighted-average basic shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Basic earnings per share (in dollars per share) Earnings Per Share, Basic Diluted EPS Earnings Per Share, Diluted, Two Class Method [Abstract] Earnings allocated to participating securities Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted Earnings available to common shareholders Net Income (Loss) Available to Common Stockholders, Diluted Weighted-average basic shares outstanding (in shares) Effect of dilutive securities (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted-average diluted shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Income Taxes Income Tax Disclosure [Text Block] Debt, Credit Facilities, and Commitments and Contingencies Debt Credit Facilities and Commitments and Contingencies Disclosure [Text Block] The entire disclosure for information about debt, credit facilities and commitments and contingencies. Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Foreign Plan [Member] Foreign Plan [Member] Retirement Plan Name [Axis] Retirement Plan Name [Axis] Retirement Plan Name [Domain] Retirement Plan Name [Domain] Pre Sixty Five Years of Age Pre Sixty Five Years Of Age [Member] Represents the health care cost trend rate for employees below 65 years age. Post Sixty Five Years of Age Post Sixty Five Years Of Age [Member] Represents the health care cost trend rate for employees above 65 years age. AbbVie Savings Plan AbbVie Savings Plan [Member] AbbVie Savings Plan [Member] Equity Securities Equity Securities [Member] Debt Securities Debt Securities [Member] Defined Benefit Plan Other Assets Projected benefit obligation Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Accumulated benefit obligations in excess of plan assets - ABO Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation Accumulated benefit obligations in excess of plan assets - PBO Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation Accumulated benefit obligations in excess of plan assets - Aggregate plan assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets Pre-tax amount of actuarial loss and prior service cost included in AOCI that is expected to be recognized in net periodic benefit cost Defined Benefit Plan, Expected Amortization, Next Fiscal Year Annual rate of increase in the per capita cost of covered health care obligation benefits assumed in the current year (as a percent) Defined Benefit Plan Health Care Obligations Trend Rate Assumed Current Fiscal Year Represents the assumed health care cost trend rate for the current year used to measure the expected cost of health care obligation benefits covered by the plan (gross eligible charges). Ultimate per capita trend rate for health care costs from 2064 and thereafter Defined Benefit Plan Ultimate Health Care Cost Trend Rate Assumed to Decrease The ultimate trend rate for health care costs assumed to decrease. Annual rate of increase in the per capita cost of covered health care cost benefits assumed in the current year (as a percent) Defined Benefit Plan Health Care Cost Trend Rate Assumed Current Fiscal Year Represents the assumed health care cost trend rate for the current year used to measure the expected cost of benefits covered by the plan (gross eligible charges). Ultimate per capita trend rate for health care costs from 2064 and thereafter (as a percent) Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Target investment allocations for Pension Plan (as a percent) Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Expenses recorded Defined Contribution Plan, Cost Book value Reported Value Measurement [Member] Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Bases used to measure the approximate fair values of the financial instruments Short-term borrowings Short-term Debt, Fair Value Current portion of long-term debt and finance lease obligations, excluding fair value hedges Long Term Debt and Capital Lease Obligations Current Fair Value Disclosure Represents the fair value amount of obligation related to long-term debt (excluding convertible debt) and capital leases, the portion which is due in one year or less in the future. Long-term debt and finance lease obligations, excluding fair value hedges Long Term Debt and Capital Lease Obligations Fair Value Disclosure Represents the fair value amount of as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer plus capital lease obligations due to be paid more than one year after the balance sheet date. Carrying amount of investments in equity securities that do not have readily determinable fair values Equity Securities without Readily Determinable Fair Value, Amount U.S. federal corporate tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Stock Options Share-based Payment Arrangement, Option [Member] Contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Exercise price for awards granted as percentage of market value on the date of grant Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Weighted-average grant-date fair value of the stock options granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding at the beginning of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Lapsed (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Outstanding at the end of the period (in shares) Exercisable at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted- average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Outstanding at the beginning of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Lapsed (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Outstanding at the end of the period (in dollars per share) Exercisable at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted- average remaining life (in years) Share Based Compensation Arrangement by Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract] Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate intrinsic value Share Based Compensation Arrangement by Share Based Payment Award Aggregate Intrinsic Value [Abstract] Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Aggregate intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Total fair value of options vested Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Segment and Geographic Area Information Segment Reporting Disclosure [Text Block] Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Domestic Current Federal Tax Expense (Benefit) Foreign Current Foreign Tax Expense (Benefit) Total current taxes Current Income Tax Expense (Benefit) Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Domestic Deferred Federal Income Tax Expense (Benefit) Foreign Deferred Foreign Income Tax Expense (Benefit) Total deferred taxes Deferred Income Tax Expense (Benefit) Total income tax expense (benefit) Licensing, Acquisitions, and Other Arrangements Licensing, Acquisitions, and Other Arrangements Acquisitions Collaborations and Other Arrangements Disclosure [Text Block] The entire disclosure for acquisitions, collaborations and other arrangements of the entity. Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] 2.90% notes due 2022 Senior Notes Due In 2022 At 2.90 Percent [Member] Represents the 2.90 percent long-term notes, which are due in 2022. 4.40% notes due 2042 Senior Notes Due In 2042 At 4.40 Percent [Member] Represents the 4.40 percent long-term notes, which are due in 2042. 2.50% notes due 2020 Senior Notes Due In 2020 At 2.50 Percent [Member] Senior Notes Due In 2020 At 2.50 Percent 3.20% notes due 2022 Senior Notes Due In 2022 At 3.20 Percent [Member] Senior Notes Due In 2022 At 3.20 Percent. 3.60% notes due 2025 Senior Notes Due In 2025 At 3.60 Percent [Member] Senior Notes Due In 2025 At 3.60 Percent. 4.50% notes due 2035 Senior Notes Due In 2035 At 4.50 Percent [Member] Senior Notes Due In 2035 At 4.50 Percent. 4.70% notes due 2045 Senior Notes Due In 2045 At 4.70 Percent [Member] Senior Notes Due In 2045 At 4.70 Percent. 2.30% notes due 2021 Senior Notes 2.30 Percent Due 2021 [Member] Represents information pertaining to the 2.30% Unsecured Senior Notes Due 2021. 2.85% notes due 2023 Senior Notes 2.85 Percent Due 2023 [Member] Represents information pertaining to the 2.85% Unsecured Senior Notes Due 2023. 3.20% notes due 2026 Senior Notes 3.20 Percent Due 2026 [Member] Represents information pertaining to the 3.20% Unsecured Senior Notes Due 2026. 4.30% notes due 2036 Senior Notes 4.30 Percent Due 2036 [Member] Represents information pertaining to the 4.30% Unsecured Senior Notes Due 2036. 4.45% notes due 2046 Senior Notes 4.45 Percent Due 2046 [Member] Represents information pertaining to the 4.45% Unsecured Senior Notes Due 2046. 0.375% notes due 2019 (€1,400 principal) Senior Euro Notes 0.38 Percent Due 2019 [Member] Senior Euro Notes 0.38 Percent Due 2019 [Member] 1.375% notes due 2024 (€1,450 principal) Senior Euro Notes 1.38 Percent Due 2024 [Member] Senior Euro Notes 1.38 Percent Due 2024 [Member] 2.125% notes due 2028 (€750 principal) Senior Euro Notes 2.13 Percent Due 2028 [Member] Senior Euro Notes 2.13 Percent Due 2028 [Member] 3.375% notes due 2021 Senior Notes Due in 2021 At 3.375 Percent [Member] Senior Notes Due in 2021 At 3.375 Percent. 3.75% notes due 2023 Senior Notes Due in 2023 At 3.75 Percent [Member] Senior Notes Due in 2023 At 3.75 Percent. 4.25% notes due 2028 Senior Notes Due in 2028 At 4.25 Percent [Member] Senior Notes Due in 2028 At 4.25 Percent. 4.875% notes due 2048 Senior Notes Due in 2048 At 4.875 Percent [Member] Senior Notes Due in 2048 At 4.875 Percent. 0.75% notes due 2027 (€750 principal) Senior Euro Notes Due in 2027 at 0.750 Percent [Member] Represents information pertaining to the 0.750% senior Euro note due in 2027. 1.25% notes due 2031 (€650 principal) Senior Euro Notes Due in 2031 at 1.250 Percent [Member] Represents information pertaining to the 1.250% senior Euro note due in 2031. Floating rate notes due May 2021 Senior Notes Due in May 2021 At Floating Rates [Member] Senior Notes Due in May 2021 At Floating Rates Floating rate notes due November 2021 Senior Notes Due in November 2021 At Floating Rates [Member] Senior Notes Due in November 2021 At Floating Rates Floating rate notes due 2022 Senior Notes Due in 2022 At Floating Rates [Member] Senior Notes Due in 2022 At Floating Rates 2.15% notes due 2021 Senior Notes Due in 2021 At 2.15 Percent [Member] Senior Notes Due in 2021 At 2.15 Percent 2.30% notes due 2022 Senior Notes Due in 2022 At 2.30 Percent [Member] Senior Notes Due in 2022 At 2.30 Percent 2.60% notes due 2024 Senior Notes Due in 2024 At 2.60 Percent [Member] Senior Notes Due in 2024 At 2.60 Percent 2.95% notes due 2026 Senior Notes Due in 2026 At 2.95 Percent [Member] Senior Notes Due in 2026 At 2.95 Percent 3.20% notes due 2029 Senior Notes Due in 2029 At 3.20 Percent [Member] Senior Notes Due in 2029 At 3.20 Percent 4.05% notes due 2039 Senior Notes Due in 2039 At 4.05 Percent [Member] Senior Notes Due in 2039 At 4.05 Percent 4.25% notes due 2049 Senior Notes Due in 2049 At 4.25 Percent [Member] Senior Notes Due in 2049 At 4.25 Percent Other Other Long Term Debt [Member] Represents information pertaining to other long-term debts. Long-term debt Debt Instrument [Line Items] Weighted-average effective interest rate Long-term Debt, Weighted Average Interest Rate, at Point in Time Long-term debt and lease obligations, gross Long Term Debt and Capital Lease Obligations, Gross Amount of long-term debt and capital lease obligations due after one year or beyond the normal operating cycle, if longer, before deduction of fair value hedges and unamortized discount. Fair value hedges Long Term Debt and Capital Lease Obligations Fair Value Hedges Represents the amount of fair value hedging, as on the balance sheet date. Unamortized bond discounts Long Term Debt and Capital Lease Obligations Debt Instrument Unamortized Discounts Represents the amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized, as on the balance sheet date. Unamortized deferred financing costs Long Term Debt And Capital Lease Obligations Debt Instrument Unamortized Financing Costs Represents the amount of deferred financing costs that was originally recognized at the issuance of the instrument that has yet to be amortized, as on the balance sheet date. Current portion Noncurrent portion Stated interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Aggregate principal amount of debt Debt Instrument, Face Amount Operating leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] 2020 Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2021 Lessee, Operating Lease, Liability, Payments, Due Year Two 2022 Lessee, Operating Lease, Liability, Payments, Due Year Three 2023 Lessee, Operating Lease, Liability, Payments, Due Year Four 2024 Lessee, Operating Lease, Liability, Payments, Due Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Total lease payments Lessee, Operating Lease, Liability, Payments, Due Less: Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Present value of lease liabilities Operating Lease, Liability Finance leases Finance Lease, Liability, Payment, Due [Abstract] 2020 Finance Lease, Liability, Payments, Remainder of Fiscal Year 2021 Finance Lease, Liability, Payments, Due Year Two 2022 Finance Lease, Liability, Payments, Due Year Three 2023 Finance Lease, Liability, Payments, Due Year Four 2024 Finance Lease, Liability, Payments, Due Year Five Thereafter Finance Lease, Liability, Payments, Due after Year Five Total lease payments Finance Lease, Liability, Payment, Due Less: Interest Finance Lease, Liability, Undiscounted Excess Amount Present value of lease liabilities Finance Lease, Liability Total Lease Liabiltiies, Payments, Due [Abstract] Lease Liabilities, Payments, Due 2020 Lease, Liability, Payments, Remainder of Fiscal Year Amount of lessee's undiscounted obligation for lease payments for operating and finance leases having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year. 2021 Lease, Liability, Payments, Due Year Two Amount of lessee's undiscounted obligation for lease payments for operating and finance leases, due in second fiscal year following latest fiscal year. 2022 Lease, Liability, Payments, Due Year Three Amount of lessee's undiscounted obligation for lease payments for operating and finance leases, due in third fiscal year following latest fiscal year. 2023 Lease, Liability, Payments, Due Year Four Amount of lessee's undiscounted obligation for lease payments for operating and finance leases, due in fourth fiscal year following latest fiscal year. 2024 Lease, Liability, Payments, Due Year Five Amount of lessee's undiscounted obligation for lease payments for operating and finance leases, due in fifth fiscal year following latest fiscal year. Thereafter Lease, Liability, Payments, Due after Year Five Amount of lessee's undiscounted obligation for lease payments for operating and finance leases, due after fifth fiscal year following latest fiscal year. Total lease payments Lease, Liability, Payments, Due Amount of lessee's undiscounted obligation for lease payments for operating and finance leases. Less: Interest Lease, Liability, Undiscounted Excess Amount Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating and finance leases. Present value of lease liabilities Contractual minimum lease payments for leases executed but not yet commenced Lessee, Lease, Lease Not yet Commenced, Contractual Minimum Payments Amount of lessee's contractual minimum lease payments for operating and finance leases that have not yet commenced. Lease term for leases executed but not yet commenced Lessee, Lease, Lease Not yet Commenced, Term of Contract Lessee, Lease, Lease Not yet Commenced, Term of Contract Schedule of quarterly financial data (unaudited) Quarterly Financial Information [Table Text Block] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization of actuarial loss and prior service credit Defined Benefit Plan, Amortization Of Actuarial Gain (Loss), Prior Service Cost (Credit) The amount of amortization of actuarial losses and prior service costs included in the calculation of net periodic pension benefit cost. Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed product rights Developed Technology Rights [Member] License agreements Licensing Agreements [Member] Definite-lived intangible assets Finite-Lived Intangible Assets [Line Items] Gross carrying amount Finite-Lived Intangible Assets, Gross Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Net carrying amount Finite-Lived Intangible Assets, Net Indefinite-lived research and development Indefinite-lived Intangible Assets (Excluding Goodwill) Total intangible assets gross carrying amount Intangible Assets, Gross (Excluding Goodwill) Total intangible assets, net Class of Treasury Stock [Table] Class of Treasury Stock [Table] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Share Repurchase Program [Domain] Share Repurchase Program [Domain] February 2017 Stock Repurchase Program February 2017 Stock Repurchase Program [Member] February 2017 Stock Repurchase Program February 2018 Stock Repurchase Program February 2018 Stock Repurchase Program [Member] February 2018 Stock Repurchase Program December 2018 Stock Repurchase Authorization December 2018 Stock Repurchase Authorization [Member] December 2018 Stock Repurchase Authorization Open Market Stock Repurchases Open Market Stock Repurchases [Member] Common stock repurchase activity associated with open market repurchases. Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Shares repurchased (in shares) Payment for shares repurchased Remaining share repurchase authorization amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Amount authorized under stock repurchase program Stock Repurchase Program, Authorized Amount Increase in authorized share repurchase amount Stock Repurchase Program, Increase In Authorized Amount Stock Repurchase Program, Increase In Authorized Amount Derivative [Table] Derivative [Table] Not designated as hedging instrument September 2019 senior Euro notes September 2019 Senior Euro Notes [Member] Represents information pertaining to the aggregate senior Euro notes which were issued in September 2019. Senior Euro notes Senior Euro Notes [Member] Senior Euro Notes [Member] Prepaid expenses and other Prepaid Expenses and Other Current Assets [Member] Other long-term liabilities Other Liabilities [Member] Derivative instruments, notional amount and fair value Derivatives, Fair Value [Line Items] Number of outstanding derivative instruments containing credit risk contingent features Number of Credit Risk Derivatives Held Notional amount of derivative instruments Derivative, Notional Amount Duration of forward exchange contracts Derivative, Term of Contract Approximate length of time over which accumulated gains and losses will be recognized in cost of products sold Maximum Length of Time Hedged in Cash Flow Hedge Treasury rate lock gain recognized in other comprehensive income (loss) Aggregate principal amount of senior Euro notes Fair value - Derivatives in asset position Fair value - Derivatives in liability position 2020 Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months 2021 Defined Benefit Plan, Expected Future Benefit Payment, Year Two 2022 Defined Benefit Plan, Expected Future Benefit Payment, Year Three 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year Four 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Five 2025 to 2029 Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter Operating cash flows from operating leases Operating Lease, Payments Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Statement of Cash Flows [Abstract] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Adjustments to reconcile net earnings to net cash from operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation Amortization of intangible assets Amortization of Intangible Assets Change in fair value of contingent consideration liabilities Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Stock-based compensation Share-based Payment Arrangement, Noncash Expense Upfront costs and milestones related to collaborations Upfront Costs Related To Collaborations Represents the amount of upfront costs related to collaborations reported in the statement of cash flows. Gain on divestitures Gain (Loss) on Disposition of Other Assets Intangible asset impairment Impairment of Intangible Assets (Excluding Goodwill) Impacts related to U.S. tax reform Impacts Related To U.S. Tax Reform The aggregate expense charged against earnings related to U.S. tax reform Other, net Other Noncash Income (Expense) Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Acquisitions and investments Payments to Acquire Other Investments Acquisitions of property and equipment Payments to Acquire Property, Plant, and Equipment Purchases of investment securities Payments to Acquire Marketable Securities Sales and maturities of investment securities Proceeds from Sale, Maturity and Collection of Investments Other Payments for (Proceeds from) Other Investing Activities Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Net change in commercial paper borrowings Proceeds from (Repayments of) Commercial Paper Proceeds from issuance of other short-term borrowings Proceeds from Other Short-term Debt Repayments of other short-term borrowings Proceeds from issuance of long-term debt Proceeds from Issuance of Long-term Debt Repayments of long-term debt and finance lease obligations Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security Debt issuance costs Payment of Financing and Stock Issuance Costs Dividends paid Payments of Dividends Purchases of treasury stock Payments for Repurchase of Common Stock Proceeds from the exercise of stock options Proceeds from Stock Options Exercised Payments of contingent consideration liabilities Payment for Contingent Consideration Liability, Financing Activities Other, net Proceeds from (Payments for) Other Financing Activities Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net change in cash and equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and equivalents, beginning of year Cash and equivalents, end of year Other supplemental information Supplemental Cash Flow Information [Abstract] Interest paid, net of portion capitalized Interest Paid, Excluding Capitalized Interest, Operating Activities Income taxes paid Income Taxes Paid Income taxes received Proceeds from Income Tax Refunds Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent event Subsequent Event [Member] Bridge credit agreement Bridge Loan [Member] Senior notes issued in 2019 Senior Notes Issued in 2019 [Member] Represents the total unsecured senior notes issued in 2019. Senior notes issued in 2019 excluding fixed-rate notes due in 2021 and 2022 Senior Notes Issued in 2019 Excluding Fixed Rate Notes Due 2021 and 2022 [Member] Represents the senior notes issued in 2019 excluding the fixed-rate notes due 2021 and 2022. June 2019 bridge credit agreement June 2019 Bridge Credit Facility [Member] June 2019 Bridge Credit Facility July 2019 term loan agreement July 2019 Term Loan Credit Agreement [Member] July 2019 Term Loan Credit Agreement July 2019 364-day term loan tranche July 2019 364-Day Term Loan Tranche [Member] July 2019 364-Day Term Loan Tranche July 2019 three-year term loan tranche July 2019 Three-Year Term Loan Tranche [Member] July 2019 Three-Year Term Loan Tranche July 2019 five-year term loan tranche July 2019 Five-Year Term Loan Tranche [Member] July 2019 Five-Year Term Loan Tranche Allergan Notes Allergan Notes [Member] Represents information pertaining to Allergan pls'c outstanding notes. Allergan Euro Notes Allergan Euro Notes [Member] Represents information pertaining to Allergan plc's Euro notes. Senior notes issued in 2018 Senior Notes Issued in 2018 [Member] Represents the total unsecured senior notes issued in 2018. September 2015 term loan agreement September 2015 Term Loan Credit Agreement [Member] September 2015 Term Loan Credit Agreement 2.00% notes due 2018 Senior Notes Due In 2018 At 2.00 Percent [Member] Represents the 2.00 percent long-term notes, which are due in 2018. 1.80% notes due 2018 Senior Notes Due In 2018 At 1.80 Percent [Member] Senior Notes Due In 2018 At 1.80 Percent. Senior notes issued in 2016 Senior Notes Issued In 2016 [Member] Represents the total unsecured senior notes issued in 2016. Senior notes issued in 2015 Senior Notes Issued in 2015 [Member] Represents the total unsecured senior notes issued in 2015. Senior notes issued in 2012 Long Term Notes Issued In2012 [Member] Senior notes issued in 2012 which includes series of senior notes as disclosed in the financial statements. Senior note redemption period prior to maturity Debt Instrument, Redemption Period Redemption period of debt instrument, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Debt issuance costs incurred Debt Issuance Costs, Gross Debt discounts Debt Instrument, Unamortized Discount Special mandatory redemption price pending the proposed acquisition Debt Instrument, Redemption Price, Percentage Bridge credit agreement maximum borrowing capacity Principal amount of borrowings Debt Instrument, Unused Borrowing Capacity, Amount Amount drawn under credit agreement Proceeds from Issuance of Debt Repayments of long-term debt Senior notes net issuance proceeds Proceeds from Debt, Net of Issuance Costs Aggregate principal amount outstanding Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-Process Research and Development In Process Research and Development [Member] Indefinite-lived intangible assets Indefinite-lived Intangible Assets [Line Items] Reclassification from indefinite-lived intangible assets Indefinite-lived Intangible Assets, Period Increase (Decrease) Indefinite-lived research and development assets Indefinite-lived intangible assets impairment charges, pre-tax Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Total earnings before income tax expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Preferred stock authorized (in shares) Preferred Stock, Shares Authorized Preferred stock par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock issued (in shares) Preferred Stock, Shares Issued Weighted Average Weighted Average [Member] Amortization period Finite-Lived Intangible Asset, Useful Life Definite-lived intangible assets impairment charges Impairment of Intangible Assets, Finite-lived Anticipated annual amortization expense Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] 2020 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2024 Finite-Lived Intangible Assets, Amortization Expense, Year Five Quarterly Financial Data [Table] Quarterly Financial Data [Table] Quarterly Financial Data [Table] Calico Life Sciences LLC Calico Life Sciences Llc [Member] Represents information pertaining to transactions with Calico Life Sciences LLC. Reata Pharmaceuticals Inc Reata Pharmaceuticals Inc [Member] Represents information pertaining to transactions with Reata Pharmaceuticals, Inc. Quarterly Financial Data Quarterly Financial Data [Line Items] [Line Items] for Quarterly Financial Data [Table] Net revenues Revenues Gross margin Gross Profit After-tax cost (benefit) related to change in fair value of contingent consideration liabilities After-tax restructuring charges Significant Restructuring Charges After Tax Significant restructuring charges, after tax After-tax charge to increase litigation reserves Loss Contingency Accrual, Provision After-tax charge as a result of a collaboration agreement extension with Calico Other Expenses After-tax intangible asset impairment charge Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill), After-Tax Amount of impairment loss, after-tax, resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. After-tax income from legal settlements Legal Settlement Income, After Tax Legal Settlement Income, After Tax After-tax consideration from counterparty for reacquired rights Consideration From Counterparty For Reacquired Rights, After Tax Consideration From Counterparty For Reacquired Rights, After Tax Income Statement [Abstract] Cost of products sold Selling, general and administrative Selling, General and Administrative Expense Research and development Research and Development Expense (Excluding Acquired in Process Cost) Acquired in-process research and development Research and Development Asset Acquired Other than Through Business Combination, Written-off Other operating expense (income) Other Operating Income (Expense), Net Total operating costs and expenses Costs and Expenses Operating earnings Operating Income (Loss) Interest expense, net Net foreign exchange loss Foreign Currency Transaction Gain (Loss), before Tax Other expense, net Other Nonoperating Income (Expense) Earnings before income tax Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income tax expense (benefit) Net earnings Per share data Earnings Per Share, Basic and Diluted [Abstract] Weighted-average diluted shares outstanding (in shares) Summary of changes in the carrying amount of goodwill Schedule of Goodwill [Table Text Block] Schedule of definite-lived intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of indefinite-lived intangible assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Schedule of anticipated annual amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Operating lease cost Operating Lease, Cost Short-term lease cost Short-term Lease, Cost Variable lease cost Variable Lease, Cost Total lease cost Lease, Cost Operating Leases, Rent Expense, Net Operating Leases, Rent Expense, Net Collaboration with Janssen Biotech, Inc. Collaborative Arrangement Disclosure [Text Block] Alector, Inc. Alector, Inc [Member] Represents information pertaining to transactions with Alector, Inc. Other individually insignificant arrangements Other Collaboration Arrangements [Member] Represents information relating to the series of other collaborative arrangements. Cash outflows related to other acquisitions and investments Consideration receivable for reacquired rights Consideration From Counterparty For Reacquired Rights Represents the consideration received from a counterparty for reacquired rights. Additional contribution to collaboration Additional Contribution To Collaboration Represents the additional contribution amount to a collaboration. Additional contribution to collaboration by partner Additional Contribution To Collaboration By Partner Represents the additional contribution amount to a collaboration by partner. Term by which the agreement was extended Term By Which The Agreement Was Extended Represents the term by which the agreement was extended. Other operating expense (income) Potential additional milestone payments Potential Payments under Agreement Certain Milestones The amount of additional payments that could be required for the achievement of certain milestones under a product agreement during the period. Changes in the carrying amount of goodwill Goodwill [Roll Forward] Balance at the beginning of the period Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Balance at the end of the period Accumulated goodwill impairment losses Goodwill, Impaired, Accumulated Impairment Loss [Abstract] Accumulated goodwill impairment losses Goodwill, Impaired, Accumulated Impairment Loss Background and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Equity Share-based Payment Arrangement [Text Block] Schedule of benefit plan information Schedule of Accumulated and Projected Benefit Obligations [Table Text Block] Summary of pretax gains and losses included in other comprehensive income (loss) Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Summary of net periodic benefit cost relating to the company's defined benefit and other post-employment plans Schedule of Net Benefit Costs [Table Text Block] Schedule of weighted-average assumptions used in determining benefit obligations at the measurement date Schedule of Key Assumptions Used in Measurement of Defined Benefit Plan Benefit Obligation [Table Text Block] Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation, including assumed discount rates and rate increase in compensation increase. Schedule of weighted-average assumptions used in determining net periodic benefit cost Schedule of Weighted Average Assumptions Used to Determine Net Periodic Pension Expense [Table Text Block] Tabular disclosure of the weighted average assumptions used to determine for pension plans and/or other employee benefit plans the net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets. Schedule of effect of 1% change in assumed health care cost trend rates Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block] Schedule of defined benefit pension plan assets Schedule of Allocation of Plan Assets [Table Text Block] Schedule of expected benefit payments Schedule of Expected Benefit Payments [Table Text Block] Effective Income Tax Rate Reconciliation, Percent [Abstract] Effective Income Tax Rate Reconciliation, Percent [Abstract] Statutory tax rate Effect of foreign operations Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent U.S. tax credits Effective Income Tax Rate Reconciliation Us Tax Credits Represents the portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to accrual of U.S. tax credits under enacted tax laws. Impacts related to U.S. tax reform Effective Income Tax Rate Reconciliation Impacts Related to U.S. Tax Reform Effective income tax rate impacts related to U.S. tax reform Stock-based compensation excess tax benefit Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent Tax audit settlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent Deferred tax remeasurements due to change in tax rate Deferred tax remeasurements due to change in tax rate Effective Income Tax Rate Reconciliation Deferred Tax Remeasurements Due To Change in Tax Rate All other, net Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent Net tax benefit related to the resolution of various tax positions pertaining to prior years Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority Recognized in Income Tax Expense Amount of (refund) expense recognized in income tax expense from examination settlement with taxing authority. Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Scenario [Axis] Scenario [Axis] Scenario [Domain] Scenario [Domain] Scenario, forecast Forecast [Member] Allergan plc Allergan plc [Member] Represents the information pertaining to Allergan plc. Business Acquisition Business Acquisition [Line Items] Total consideration Business Combination, Consideration Transferred Closing price of AbbVie's common stock Share Price Shares of AbbVie stock received by Allergan shareholders Business Combination Consideration Transferred Number Of Shares Issued Per One Share Of Acquired Entity Represents the number of shares issued by the acquiring entity per one share of acquired entity. Cash per share received by Allergan shareholders Business Acquisition, Share Price Leases Leases of Lessee Disclosure [Text Block] Schedule of basic and diluted earnings per share, impact of two-class method Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of profit and cost sharing relationship Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block] Fair Value, Transfers Between Level 1 and Level 2 Fair Value, Transfers Between Level 1 and Level 2, Description and Policy [Abstract] Transfer of assets from level 1 to level 2 Fair Value, Assets, Level 1 to Level 2 Transfers, Amount Transfer of assets from level 2 to level 1 Fair Value, Assets, Level 2 to Level 1 Transfers, Amount Transfer of liabilities from level 1 to level 2 Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount Transfer of liabilities from level 2 to level 1 Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount Change in fair value of liabilities measured using level 3 inputs Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Ending balance Japan JAPAN Germany GERMANY Canada CANADA France FRANCE Spain SPAIN United Kingdom UNITED KINGDOM Italy ITALY Brazil BRAZIL The Netherlands NETHERLANDS All other countries Other Countries [Member] Represents information pertaining to other countries not specified anywhere. Net revenues Revenue from Contract with Customer, Excluding Assessed Tax Foreign currency translation adjustments, net of tax expense (benefit) of $(4) in 2019, $(18) in 2018 and $34 in 2017 Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Net investment hedging activities, net of tax expense (benefit) of $22 in 2019, $40 in 2018 and $(194) in 2017 Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), After Reclassification and Tax, Portion Attributable to Parent Amount, after tax and reclassification, of gain (loss) from derivative instruments and nonderivative instruments designated and qualifying as net investment hedge, attributable to parent entity. Pension and post-employment benefits, net of tax expense (benefit) of $(323) in 2019, $35 in 2018 and $(94) in 2017 Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Marketable security activities, net of tax expense (benefit) of $— in 2019, $— in 2018 and $(8) in 2017 Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Cash flow hedging activities, net of tax expense (benefit) of $70 in 2019, $23 in 2018 and $(26) in 2017 Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Other comprehensive income (loss) Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] AOCI Attributable to Parent Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Net investment hedging activities Accumulated Net Gain (Loss) From Net Investment Hedges Attributable To Parent [Member] Accumulated Net Gain (Loss) From Net Investment Hedges Attributable To Parent [Member] Marketable security activities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Other comprehensive income (loss) before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent Net losses reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Currency translation adjustment reclassification from AOCI tax impact Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax Schedule of share-based compensation expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Summary of AbbVie stock option activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Summary of AbbVie RSA and RSU activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Summary of quarterly cash dividends Schedule of Dividends Payable [Table Text Block] Summary of changes in each component of accumulated other comprehensive loss, net of tax Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of the impact of significant amounts reclassified out of each component of accumulated other comprehensive loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Legal Proceedings and Contingencies Legal Matters and Contingencies [Text Block] Schedule of interest expense, net Interest Income and Interest Expense Disclosure [Table Text Block] Schedule of accounts payable and accrued liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of other long-term liabilities Other Noncurrent Liabilities [Table Text Block] Finished goods Inventory, Finished Goods, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Raw materials Inventory, Raw Materials, Net of Reserves Inventories Deferred tax assets Components of Deferred Tax Assets [Abstract] Compensation and employee benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Accruals and reserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Chargebacks and rebates Chargebacks and rebates Amount before allocation of valuation allowances of deferred tax asset attributable to deductible chargebacks and rebates. Advance payments Deferred Tax Assets, Deferred Income Net operating losses and other credit carryforwards Net operating losses and other credit carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and other tax credit carryforwards. Other Deferred Tax Assets, Other Total deferred tax assets Deferred Tax Assets, Gross Valuation allowances Deferred Tax Assets, Valuation Allowance Total net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Deferred tax liabilities Components of Deferred Tax Liabilities [Abstract] Excess of book basis over tax basis of intangible assets Deferred Tax Liabilities, Intangible Assets Excess of book basis over tax basis in investments Deferred Tax Liabilities, Investments Other Deferred Tax Liabilities, Other Total deferred tax liabilities Deferred Tax Liabilities, Gross Net deferred tax liabilities Deferred Tax Liabilities, Net Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] State And Local Jurisdiction State and Local Jurisdiction [Member] Foreign Country Foreign Tax Authority [Member] Tax Credit Carryforward [Line Items] Tax Credit Carryforward [Line Items] Operating loss carryforwards Operating Loss Carryforwards Tax credit carryforwards Tax Credit Carryforward, Amount Operating loss carryforwards with expiration between 2018 and 2023 Operating Loss Carryforwards With Expiration Amount of operating loss carryforward with expiration day between 2018 and 2023, before tax effects, available to reduce future taxable income under enacted tax laws. Summary of long-term debt Schedule of Long-term Debt Instruments [Table Text Block] Summary of maturities of long-term debt Schedule of Maturities of Long-term Debt [Table Text Block] Revenue from Contract with Customer [Abstract] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Key Product Portfolio [Axis] Key Product Portfolio [Axis] Information concerning the company's portfolios of key products. Key Product Portfolio [Domain] Key Product Portfolio [Domain] [Domain] for Information concerning the company's portfolios of key products. Immunology Immunology [Member] Represents information pertaining to Immunology, a key product portfolio of the entity. Hematologic Oncology Hematologic Oncology [Member] Represents information pertaining to Hematologic Oncology, a key product portfolio of the entity. HCV HCV [Member] Represents information pertaining to HCV, a key product portfolio of the entity. Other Key Products Other Key Products [Member] Represents information pertaining to other key products of the entity. HUMIRA H U M I R A [Member] Represents information pertaining to HUMIRA, a product of the entity. RINVOQ RINVOQ [Member] Represents information pertaining to RINVOQ, a product of the entity. IMBRUVICA Imbruvica [Member] Represents information pertaining to Imbruvica, a product of the entity. VENCLEXTA VENCLEXTA [Member] Represents information pertaining to VENCLEXTA, a product of the entity. MAVYRET MAVYRET [Member] Represents information pertaining to MAVYRET, a product of the entity. VIEKIRA VIEKIRA [Member] Represents information pertaining to VIEKIRA, a product of the entity. Creon Creon [Member] Represents information pertaining to Creon, a product of the entity. Lupron Lupron [Member] Represents information pertaining to Lupron, a product of the entity. Synthroid Synthroid [Member] Represents information pertaining to Synthroid, a product of the entity. Synagis Synagis [Member] Represents information pertaining to Synagis, a product of the entity. Duodopa Duodopa [Member] Represents information pertaining to Duodopa, a product of the entity. Sevoflurane Sevoflurane [Member] Represents information pertaining to Sevoflurane, a product of the entity. Kaletra Kaletra [Member] Represents information pertaining to Kaletra, a product of the entity. AndroGel Andro Gel [Member] Represents information pertaining to AndroGel, a product of the entity. ORILISSA ORILISSA [Member] Represents information pertaining to ORILISSA, a product of the entity. All other Other Products [Member] Represents information pertaining to other products of the entity not specified anywhere. Disaggregation of Revenue Disaggregation of Revenue [Line Items] Cost of products sold Research and development Research and Development Expense [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Shares reserved for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Retirement-eligible employees' age Share Based Compensation Arrangement By Share Based Payment Award Retirement Eligible Age Represents retirement eligible employees' age. Minimum number of years of services Share Based Compensation Arrangement By Share Based Payment Award Retirement Eligible Employees Number Of Years Of Services Represents the minimum of number of years of services that employees have to work for the company in order to be eligible to retire with benefits. Pre-tax compensation expense Share-based Payment Arrangement, Expense Tax benefit Share-based Payment Arrangement, Expense, Tax Benefit After-tax compensation expense Share-based Payment Arrangement, Expense, after Tax Realized excess tax benefits from the exercise of stock options Excess Tax Benefit from Share-based Compensation, Operating Activities Summary of amounts and location of derivatives on the consolidated balance sheets Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Schedule of pre-tax amounts of derivatives recognized in other comprehensive income (loss) Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Summary of pre-tax amounts and location of derivatives recognized in the consolidated statement of earnings Derivative Instruments, Gain (Loss) [Table Text Block] Summary of bases used to measure assets and liabilities carried at fair value on a recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of changes in fair value of contingent consideration liabilities which are measured using Level 3 inputs Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of book values, approximate fair values and bases used to measure certain financial instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Summary of available-for-sale securities by type Available-for-sale Securities [Table Text Block]